In this Issue:
Added sugar intake increases CV disease mortality
Cardiac injury markers can be unreliable
DAPT after DES: 6 months may be enough
PCI for previously treated vs de novo culprit lesions
Bivalirudin vs UFH after coronary angioplasty
Risk score for predicting mortality in ICD patients
Statins have benefits in patients with HFPEF
Aleglitazar fails to deliver
Statin combination therapy vs monotherapy
Reassess antiplatelet therapy + warfarin use
Please login below to download this issue (PDF)